Could psychedelic drugs be the future of medicine? | The Big Story

Psychedelic substances are currently under investigation for their profound medicinal potential across a range of mental disorders. Research suggests that these compounds can reset brain circuits and networks, offering a promising alternative for treating conditions like depression and anxiety. While high-dose experiences are standard in clinical trials, significant questions remain regarding the therapeutic role of low-dose microdosing and the necessity of the subjective psychedelic experience in attaining long-term psychiatric benefits. Caution is warranted in interpreting early findings, as large-scale, robust evidence regarding safety and long-term efficacy is still being developed.